Ckd Bio (063160) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-907.63 Million ≈ $-615.09K USD) by net assets (₩127.04 Billion ≈ $86.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ckd Bio - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ckd Bio debt and liabilities for a breakdown of total debt and financial obligations.

Ckd Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GLOSTER LTD (BSE) NSE:GLOSTERLTD	-0.078x
MedFirst Healthcare Services lnc TWO:4175	0.076x
Eureka Acquisition Corp Unit NASDAQ:EURKU	-0.006x
Invictus Energy Ltd AU:IVZ	-0.018x
SP Systems Co.Ltd KQ:317830	0.010x
Man Zai Industrial Co Ltd TWO:4543	0.031x
Metrofile JSE:MFL	0.237x
Siebert Financial Corp NASDAQ:SIEB	0.005x

Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Ckd Bio.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩127.04 Billion ≈ $86.09 Million	₩-4.14 Billion ≈ $-2.81 Million	-0.033x	-130.45%
2024-12-31	₩131.01 Billion ≈ $88.78 Million	₩14.03 Billion ≈ $9.51 Million	0.107x	+282.39%
2023-12-31	₩123.02 Billion ≈ $83.37 Million	₩-7.22 Billion ≈ $-4.90 Million	-0.059x	-170.82%
2022-12-31	₩147.80 Billion ≈ $100.16 Million	₩-3.20 Billion ≈ $-2.17 Million	-0.022x	+40.47%
2021-12-31	₩161.49 Billion ≈ $109.44 Million	₩-5.88 Billion ≈ $-3.99 Million	-0.036x	-227.41%
2020-12-31	₩168.75 Billion ≈ $114.36 Million	₩4.82 Billion ≈ $3.27 Million	0.029x	-73.34%
2019-12-31	₩158.46 Billion ≈ $107.39 Million	₩16.99 Billion ≈ $11.51 Million	0.107x	+1.91%
2018-12-31	₩147.66 Billion ≈ $100.07 Million	₩15.54 Billion ≈ $10.53 Million	0.105x	-26.90%
2017-12-31	₩142.05 Billion ≈ $96.26 Million	₩20.45 Billion ≈ $13.86 Million	0.144x	+25.52%
2016-12-31	₩135.16 Billion ≈ $91.60 Million	₩15.50 Billion ≈ $10.50 Million	0.115x	+1.87%
2015-12-31	₩127.38 Billion ≈ $86.32 Million	₩14.34 Billion ≈ $9.72 Million	0.113x	+22.22%
2014-12-31	₩121.85 Billion ≈ $82.57 Million	₩11.22 Billion ≈ $7.61 Million	0.092x	+4.45%
2013-12-31	₩123.87 Billion ≈ $83.95 Million	₩10.92 Billion ≈ $7.40 Million	0.088x	-52.19%
2012-12-31	₩124.15 Billion ≈ $84.13 Million	₩22.90 Billion ≈ $15.52 Million	0.184x	+69.33%
2011-12-31	₩119.00 Billion ≈ $80.65 Million	₩12.96 Billion ≈ $8.79 Million	0.109x	-65.28%
2010-12-31	₩76.14 Billion ≈ $51.60 Million	₩23.89 Billion ≈ $16.19 Million	0.314x	-24.35%
2009-12-31	₩64.08 Billion ≈ $43.42 Million	₩26.57 Billion ≈ $18.01 Million	0.415x	+90.70%
2008-12-31	₩49.15 Billion ≈ $33.31 Million	₩10.69 Billion ≈ $7.24 Million	0.217x	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$72.53 Million

₩107.03 Billion KRW

Market Cap Rank

#20438 Global

#1192 in Korea

Share Price

₩19510.00

Change (1 day)

-0.61%

52-Week Range

₩18470.00 - ₩24500.00

All Time High

₩101057.67